1
Deutsches Herzzentrum Berlin
– TAVI TEAM –
List of Publications 2010 – 2013 (as of 28.01.2013)
Total Impact Factor (as of 29. January 2013) = 110,946
38. Unbehaun A, Pasic M, Drews T, Buz S, Dreysse S, Kukucka M, Mladenow A,
Ivanitskaja-Kühn E, Hetzer R. New 29-mm balloon-expandable prosthesis for
transcatheter aortic valve implantation in large annuli. Ann Thorac Surg 2013;
(accepted).
Impact factor = 3.741
37. Pasic M, Unbehaun A, Dreysse S, Buz S, Drews T, Kukucka M, Mladenow A,
D'Ancona G, Hetzer R, Seifert B. Introducing transapical aortic valve implantation
(part 1): Effect of a structured training program on clinical outcome in a series of 500
procedures. J Thorac Cardiovasc Surg 2013; doi:pii: S0022-5223(12)01641-8.
10.1016/j.jtcvs.2012.12.057.
Impact factor = 3.406
36. Pasic M, Unbehaun A, Dreysse S, Buz S, Drews T, Kukucka M, Mladenow A,
Hetzer R, D'Ancona G. Introducing transapical aortic valve implantation (part 2):
Institutional structured training program. J Thorac Cardiovasc Surg 2013;
doi.org/10.1016/j.jtcvs.2012.12.085.
Impact factor = 3.406
35. Drews T, Pasic M, Buz S, d'Ancona G, Dreysse S, Kukucka M, Mladenow A,
Hetzer R, Unbehaun A. Transcatheter aortic valve implantation in very high-risk
Patients with EuroSCORE of more than 40%. Ann Thorac Surg 2013; 95: 85-93.
Impact factor = 3.741
34. Kukucka M, Pasic M, Dreysse S, Mladenow A, Habazettl H, Hetzer R, Unbehaun
A. Patient-prosthesis mismatch after transapical aortic valve implantation: Incidence
and impact on survival. J Thorac Cardiovasc Surg 2013; 145: 391-7.
Impact factor = 3.406
33. Drews T, Pasic M, Buz S, D'Ancona G, Mladenow A, Hetzer R, Unbehaun A.
Elective femoro-femoral cardiopulmonary bypass during transcatheter aortic valve
implantation: A useful tool. J Thorac Cardiovasc Surg 2012; doi:10.1016/j.jtcvs.2012.
02.
Impact factor = 3.406
32. Kukucka M, Pasic M, Unbehaun A, Dreysse S, Mladenow A, Habazettl H, Hetzer
R. Hemodynamic characteristics of Edwards sapien aortic valve prosthesis assessed
with transesophageal echocardiography. J Heart Valve Dis 2012; 21: 662-9.
Impact factor = 0.811
1
2
31. D'Ancona G, Pasic M, Dreysse S, Drews T, Buz S, Unbehaun A, Kukucka M,
Hetzer R. Transcatheter aortic valve implantation into a stentless prosthetic valve
with a low position of the left main coronary artery. Heart Surg Forum 2012; 15: E
268-71.
Impact factor = 0.416
30. Drews T, Pasic M, Buz S, Unbehaun A. Reply to Dainese. Eur J Cardiothoracic
Surg 2012; 42: 604.
Impact factor = 2.550
29. Buz S, Pasic M, Unbehaun A, Hetzer R. Transcatheter aortic valve implantation
in Jehovah's Witness patients with symptomatic severe aortic valve stenosis. Interact
Cardiovasc Thorac Surg 2012; 15: 766-8.
Impact factor = --- (to be determined in June 2013)
28. Pasic M, Unbehaun A, Dreysse S, Buz S, Drews T, Kukucka M, D'Ancona G,
Seifert B, Hetzer R. Rupture of the device landing zone during transcatheter aortic
valve implantation: a life-threatening but treatable complication. Circ Cardiovasc
Interv 2012; 5: 424-32.
Impact factor = 6.058
27. Pasic M, Buz S, Unbehaun A, Hetzer R. Transcatheter aortic valve implantation
combined with conventional heart surgery: hybrid approach for complex cardiac
pathologic features. J Thorac Cardiovasc Surg 2012; 144: 728-31.
Impact factor = 3.406
26. Unbehaun A, Pasic M, Buz S, Dreysse S, Kukucka M, Hetzer R, Drews T.
Transapical aortic valve implantation in patients with severely depressed left
ventricular function. J Thorac Cardiovasc Surg 2012; 143: 1356-63.
Impact factor = 3.406
25. Pasic M, Dreysse S, Unbehaun A, Buz S, Drews T, Klein C, D'Ancona G, Hetzer
R. Combined elective percutaneous coronary intervention and transapical
transcatheter aortic valve implantation. Interact Cardiovasc Thorac Surg
2012;14:463-8.
Impact factor = --- (to be determined in June 2013)
24. D’Ancona G, Pasic M, Buz S, Drews T, Dreysse S, Kukucka M, Hetzer R,
Unbehaun A. Transapical transcatheter aortic valve replacement in patients with
cardiogenic shock. Interact Cardiovasc Thorac Surg 2012;14:426-30.
Impact factor = --- (to be determined in June 2013)
23. Pasic M, Dreysse S, Potapov E, Unbehaun A, Buz S, Drews T, D’Ancona G,
Schäfer K, Kukucka M, Mladenow A, Hetzer R. Rescue transcatheter aortic valve
implantation and simultaneous percutaneous coronary intervention on
cardiopulmonary bypass in a patient with an extreme risk profile. Heart Surg Forum
2012; 15:E164-6.
Impact factor = 0.416
2
3
22. D’Ancona G, Pasic M, Buz S, Drews T, Dreysse S, Hetzer R, Unbehaun A. TAVI
for pure aortic valve insufficiency in a patient with LVAD. Ann Thorac Surg
2012;93:e89–91.
Impact factor = 3.741
21. Drews T. Transcatheter aortic valve implantation after previous coronary artery
bypass grafting: a potential gold standard of care. (editorial comment). Eur J
Cardiothorac Surg 2012; 41: 504–5.
Impact factor = 2.550
20. Unbehaun A, Pasic M, Dreysse S, Drews T, Kukucka M, Mladenow A,
Ivanitskaja-Kühn E, Hetzer E, Buz S. Transapical aortic valve implantation: Incidence
and predictors of paravalvular leakage and transvalvular regurgitation in a series of
358 patients. J Am Coll Cardiol 2012; 59: 211-21.
Impact factor = 14.156
19. Unbehaun A, Pasic M, Dreysse S, Buz S, Kukucka M, Hetzer R, Drews T.
Transcatheter aortic valve implantation and hybrid coronary artery revascularization time to combine them. Innovations 2011; 6:395-8.
Impact factor = --- (to be determined in June 2013)
18. Pasic M, D'Ancona G, Drews T, Buz S, Hetzer R, Höck M, Unbehaun A.
Transapical aortic valve implantation: A prospective evaluation of anterior
thoracotomy wound complications. Ann Thorac Surg 2012; 93: 357-8.
Impact factor = 3.741
17. Pasic M, Zipfel B, Drews T, Dreysse S, Unbehaun A, Buz S, Kukucka M,
D’Ancona G, Hetzer R. Transapical placement of an uncovered aortic endostent for
type A aortic dissection. Circ Cardiovasc Interv 2011; 4: e49-e53
Impact factor = 6.058
16. Pasic M, Berger F, D’Ancona G, Dreysse S, Buz S, Drews T, Hetzer R,
Unbehaun A, Kukucka M. Transcatheter aortic valve implantation and simultaneous
closure of ostium secundum atrial septal defect. Heart Surg Forum 2011;
2011;14:e354-e6.
Impact factor = 0.416
15. Pasic M, Unbehaun A, Buz S, Drews T, Hetzer R. Transapical aortic valve
implantation and “off-pump” arterial coronary bypass in a patient with porcelain aorta.
J Heart Valve Dis 2011; 20:711-4.
Impact factor = 0.811
14. Unbehaun A, Pasic M, Drews T, Dreysse S, Kukucka M, Hetzer R, Buz S.
Analysis of survival in 300 high-risk patients up to 2.5 years after transapical aortic
valve Implantation. Ann Thorac Surg 2011; 92:1315-23.
Impact factor = 3.741
13. Pasic M, Unbehaun A, Drews T, Hetzer R. Late wound healing problems after
use of BioGlue for apical hemostasis during transapical aortic valve implantation.
Interact Cardiovasc Thorac Surg 2011; 13: 532-4.
Impact factor = --- (to be determined in June 2013)
3
4
12. D'Ancona G, Pasic M, Unbehaun A, Hetzer R. Permanent pacemaker
implantation after transapical transcatheter aortic valve implantation. Interact
Cardiovasc Thorac Surg 2011; 13 :373-6.
Impact factor = --- (to be determined in June 2013)
11. O'Brien B, Pasic M, Kuppe H, Hetzer R, Habazettl H, Kukucka M. A transapical or
transluminal approach to aortic valve implantation does not attenuate the
inflammatory response. Heart Surg Forum 2011; 14: E110-3.
Impact factor = 0.811
10. Drews T, Pasic M, Buz S, Unbehaun A. Trans-catheter aortic valve implantation
after previous aortic homograft surgery. Eur J Cardiothorac Surg 2011; 40: 1534-6.
Impact factor = 2.550
9. Drews T, Pasic M, Buz S, Unbehaun A, Dreysse S, Kukucka M, Mladenow A,
Hetzer R. Transcranial Doppler sound detection of cerebral microembolism during
transapical aortic valve implantation. Thorac Cardiovasc Surg 2011; 59:237-42.
Impact factor = 0.882
8. Buz S, Pasic M, Unbehaun A, Drews T, Dreysse S, Kukucka M, Mladenow A,
Hetzer R. Trans-apical aortic valve implantation in patients with severe calcification of
the ascending aorta. Eur J Cardiothorac Surg 2011; 40: 463-8.
Impact factor = 2.550
7. Kukucka M, Pasic M, Dreysse S, Hetzer R. Delayed subtotal coronary obstruction
after transapical aortic valve implantation. Interact Cardiovasc Thorac Surg 2011; 12:
57-60.
Impact factor = --- (to be determined in June 2013)
6. Pasic M, Unbehaun A, Dreysse S, Buz S, Drews T, Kukucka M, Hetzer R.
Transapical aortic valve implantation after previous aortic valve replacement: clinical
proof of the "valve-in-valve" concept. J Thorac Cardiovasc Surg 2011; 142: 270-7.
Impact factor = 3.406
5. Drews T, Pasic M, Buz S, Unbehaun A, Dreysse S, Kukucka M, Mladenow A,
Hetzer R. Transapical aortic valve implantation after previous mitral valve surgery. J
Thorac Cardiovasc Surg 2011; 142: 84-8.
Impact factor = 3.406
4. Drews T, Pasic M, Buz S, Unbehaun A, Dreysse S, Kukucka M, Mladenow A,
Hetzer R. Transapical aortic valve implantation after previous heart surgery. Eur J
Cardiothorac Surg 2011; 39 :625-30.
Impact factor = 2.550
3. Pasic M, Buz S, Dreysse S, Drews T, Unbehaun A, Klein C, Kukucka M,
Mladenow A, Ivanitskaia-Kühn E, Hetzer R. Transapical aortic valve implantation in
194 patients: problems, complications, and solutions. Ann Thorac Surg 2010;
90 :1463-70.
Impact factor = 3.558
4
5
2. Pasic M, Unbehaun A, Dreysse S, Drews T, Buz S, Kukucka M, Mladenow A,
Gromann T, Hetzer R. Transapical aortic valve implantation in 175 consecutive
patients: excellent outcome in very high-risk patients. J Am Coll Cardiol 2010 31; 56:
813-20
Impact factor = 14.292
1. Pasic M, Dreysse S, Drews T, Buz S, Unbehaun A, Kukucka M, Mladenow A,
Hetzer R. Improved technique of transapical aortic valve implantation: "the Berlin
addition". Ann Thorac Surg 2010; 89: 2058-60.
Impact factor = 3.558
5